Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | lamin dm0 | 0.0028 | 0.1359 | 0.1614 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.3057 | 0.3633 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0105 | 0.8417 | 1 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0105 | 0.8417 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.1359 | 0.1236 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.1359 | 0.1359 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0105 | 0.8417 | 1 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.1359 | 0.1236 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.1359 | 0.1359 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0105 | 0.8417 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.0028 | 0.1359 | 0.1614 |
Echinococcus granulosus | lamin | 0.0028 | 0.1359 | 0.1614 |
Schistosoma mansoni | lamin | 0.0028 | 0.1359 | 0.151 |
Echinococcus multilocularis | musashi | 0.0028 | 0.1359 | 0.1614 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 1 | 1 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.007 | 0.519 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.007 | 0.519 | 0.6119 |
Brugia malayi | Melibiase family protein | 0.007 | 0.519 | 0.5122 |
Onchocerca volvulus | Huntingtin homolog | 0.0122 | 1 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0105 | 0.8417 | 1 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0105 | 0.8417 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.3057 | 0.3633 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0139 | 0.0139 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.519 | 0.519 |
Echinococcus multilocularis | lamin | 0.0028 | 0.1359 | 0.1614 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.3057 | 0.3633 |
Schistosoma mansoni | intermediate filament proteins | 0.0028 | 0.1359 | 0.151 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.3057 | 0.3633 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.3057 | 0.3553 |
Echinococcus granulosus | intermediate filament protein | 0.0028 | 0.1359 | 0.1614 |
Schistosoma mansoni | lamin | 0.0028 | 0.1359 | 0.151 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.007 | 0.519 | 0.6119 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.3057 | 0.2959 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0105 | 0.8417 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.3057 | 0.3553 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.1311 | 0.1311 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.1359 | 0.1359 |
Toxoplasma gondii | melibiase subfamily protein | 0.0105 | 0.8417 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.0122 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.3057 | 0.3553 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.3057 | 0.3057 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 21 % | DNDI: Inhibition of Human African Trypanosomiasis, SBRI 427, in vitro at 2 ug.mL-1 | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.